Make better decisions with better MRD testing
Unmatched sensitivity and specificity for confident MRD detection. Interested in learning more about using Haystack MRD™?
See what other tests can't
Haystack Oncology uses the next generation of circulating tumor DNA (ctDNA) detection technology to see through the noise and uncover residual, recurrent, and resistant disease earlier than any other minimal residual disease (MRD) test.
MRD testing demands the most sensitive ctDNA detection. The Haystack MRD Test is a tumor-informed ctDNA test that is specifically designed for post-surgical MRD applications.
Why choose Haystack MRD?
Built by giants
Haystack Oncology was founded by pioneers in blood-based diagnostics who were the first to envision a revolution in patient care made possible by groundbreaking molecular methods.
News & Events
Find out what's happening at Haystack Oncology and stay up-to-date with industry news.